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energy and 72.72 kJ/M energy was used in case of osteoarthritic
samples. Loss of water content in all three groups are presented
with a sharp step on the TG curve, starting on average tempera-
ture of 37 °C and ending at 116 °C. Linear part of the TG curve
begun at around 62 °C and ended at around 112 °C. loss. In
case of the normal hyaline cartilage 1.266%/1°C fluid loss was
detected. In necrotic samples 1.689%/1 °C decrease in mass
was observed. In the osteoarthritic 1.422%/1 °C mass reduction
was measured
Conclusions: Increase in the cartilage matrix water content in all
cases of degenerative articular cartilage was observed. Based on
the results it can be stated that water content is higher in impaired
samples, meanwhile water interstitial bonding was stronger in
these cases. Activation energy correlated considerably with water
content in the samples. The newly established thermogravimetric
protocol was sufficient for compositional thermoanalytical study
of normal and degenerative human hyaline cartilage. Previously,
this method has not been used for this purpose. Characterization
of the altered metabolism in cartilage that promote disease
progression should lead to future treatment options that can
prevent structural damage. Therapeutic steps can be adequately
tested and monitored with thermogravimetric measurements.
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EVIDENCE FOR CLEAVAGE OF TYPE II COLLAGEN BY
CATHEPSIN K IN HUMAN OSTEOARTHRITIC CARTILAGE
V.M. Dejica, J.S. Mort, A.R. Poole
Shriners Hospital, Montreal, PQ, Canada
Purpose: Cathepsin K is expressed in normal and osteoarthritic
(OA) hyaline cartilage and is capable of cleaving type II collagen
as well as other matrix molecules. The aim of this study was to
determine whether there is evidence for cathepsin K- mediated
cleavage of type II collagen in human OA cartilage.
Methods: Femoral condylar cartilages removed at arthroplasty
for knee OA were cultured in serum-free medium in the presence
and absence of a synthetic cathepsin K inhibitor (supplied by
Merck Frosst, Montreal, Quebec, Canada). The content of a new
type II collagen cleavage neoepitope that can be generated by
cathepsin K was measured by ELISA assay. Aggrecan degrada-
tion was measured by the release of glycosaminoglycan using a
colorimetric assay. Inhibitor toxicity was assessed by measuring
the incorporation of [3H] proline in cartilage cultured with and
without the inhibitor. Type II collagen cleavage was also detected
by ELISA and immunohistochemically in uncultured cartilages
from both normal and OA knee joints.
Results: Cleavage of type II collagen was significantly enhanced
in OA cartilage compared with healthy cartilage, as demonstrated
by ELISA and immunolocalization. The inhibitor reduced collagen
cleavage in cultures of 4 out of 8 patients, this being significant
in 3 cases. There was no effect on proteoglycan release and the
incorporation of tritiated proline was unaffected by the inhibitor.
Conclusions: These results show that cleavage of type II colla-
gen at a site cleaved by cathepsin K is increased in OA articular
cartilages. Based on the specificity and lack of detectable tox-
icity of the inhibitor, this cleavage is due in part to cathepsin
K in almost half of the patients. Cathepsin K should therefore
be considered as a potential therapeutic target in the control of
cartilage degeneration in OA.
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BOVINE, PORCINE AND ICHTHYIC CHONDROITIN
SULFATE DECREASE IL-1beta EFFECTS ON NO
PRODUCTION AND APOPTOSIS: CORRELATION WITH
MOLECULAR MODELING DATA
F. Heraud1, F. Burger1, E. Rebuffet2, S. Amigues1, C. Soler1,
A. Imberty2
1Laboratoires Genevrier, Sophia Antipolis, France,
2CERMAV-CNRS, Grenoble, France
Purpose: The current study examines whether porcine, bovine
and ichthyic chondroitin sulfate (CS) would influence the produc-
tion of nitric oxide (NO) and apoptosis in human osteoarthritic
(OA) chondrocytes. Then, we confirm these results and explain
them by a proposed novel activity concept of CS evaluated by
molecular modeling.
Methods: Samples of human OA articular cartilage were ob-
tained from patients undergoing knee arthroscopy. Firstly, OA
human chondrocytes were incubated with porcine, bovine and
ichthyic CS (100μg/mL) and stimulated with human recombinant
Interleukin-1 beta (hrIL-1 beta) (10ng/mL), in the same time, to
induce NO synthesis. NO release was measured as nitrite con-
centration in 24 and 48 hours culture supernatants by using the
Griess reaction. Secondly, OA human chondrocytes were incu-
bated with porcine, bovine and ichthyic CS during 72 hours and
stimulated by various concentrations SNP (Sodium Nitroprus-
side) during 18 hours. SNP was used as a NO compound donor.
To access the degree of apoptosis, APOPercentage Apoptosis
Assay was used. This finding was further quantitatively confirmed
by fluorescent microscopy using two apoptosis markers: TUNEL
assay and Annexin-V fluos. In the third time, we modelized sev-
eral CS oligosaccharides and we have tested their possibilities
of interaction with IL-1 beta and its receptor.
Results: Bovine, porcine and ichthyic CS tested decreased
significantly NO synthesis at 48 hours when human OA chon-
drocytes were cotreated with CS and hrIL-1beta. However, a
preventive treatment with bovine, porcine and ichthyic CS dur-
ing 72 hours and a stimulation with hrIL-1beta did not reduce
significantly NO synthesis.
In OA chondrocytes treated with bovine, porcine and ichthyic
CS, on average 18% of chondrocytes showed apoptotic features
compared with 31% in chondrocytes treated with SNP. These
data suggest that CS or CS oligosaccharides could interact with
IL-1beta. The modeling study proposed two sites of interactions
between IL-1 beta and some oligosaccharides. We have probed
the specificity of this protein for distinct sulphatation sequences.
Conclusions: These results suggest that bovine, porcine and
ichthyic CS prevent IL-1beta induced increase in NO production.
This preliminary study suggests that bovine, porcine and ichthyic
CS could downregulate apoptosis in the OA chondrocytes. A
decrease of IL-1 beta effects could be the consequence of
specific binding to oligosaccharides.
This study provides a plausible mechanism for the chondropro-
tective properties of bovine, porcine and ichthyic CS.
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CHONDROCYTE HYPERTROPHY - A NOVEL EX VIVO
MODEL FOR EARLY CHANGES IN CHONDROCYTES IN
OA
B.-C. Sondergaard1, S.H. Madsen1, P. Qvist1, C. Christiansen2,
M.A. Karsdal1
1Nordic Bioscience Diagnostics, Herlev, Denmark, 2CCBR,
Ballerup, Denmark
Purpose: In early osteoarthritis (OA), hypertrophic chondrocytes
are part of the pathology and are distributed throughout the
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articular cartilage matrix. The de-differentiation of chondrocytes
in OA may be an early event, that properly counteracted could
provide a novel rationale and advance new drugs for OA. We
wanted to develop a model system for early stage OA in an
more in-vivo like ex vivo setting, using growth factors known to
stimulate hypertrophy in various cell-lines.
Methods: Articular cartilage explants was harvested from bovine
stifle joints and cultured with either bFGF [20 ng/mL], BMP-2
[20 ng/mL], or β-glycerol-phosphate [50 μg/mL] and ascorbic
acid [10 mM] to stimulate the hypertrophic phenotype of the
articular chondrocytes. Cultures was refreshed every other day
and cultured for three weeks. The morphology was followed by
histology by toluidine blue staining, and immunohistochemistry of
hypertrophy markers: collagen type X, matrix metalloproteinase
13 (MMP-13), and alkaline phosphatase (ALP). Additionally, the
CTX-II Ab was used to evaluate the contribution of collagen type
II telopeptides fragments.
Results: Changes in morphology towards the hypertrophic phe-
notype after bFGF stimulation were associated with large chon-
drocytes and expression of collagen type X and ALP in the artic-
ular cartilage matrix. BMP-2 also stimulated hypertrophy in the
articular cartilage explants, but only expression of ALP and MMP-
13 was found. Hypertrophy induced by β-glycerol-phosphate and
ascorbic acid, showed expression of all markers: ALP, MMP-
13 Collagen type X (to a lesser extent), and CTX-II fragments.
When all inducers of hypertrophy were combined (bFGF, BMP-2,
β-glycerol-phosphate and ascorbic acid), changes in morphology
into the hypertrophic phenotype were found, expression of ALP,
MMP-13, and CTX-II, but not collagen type X.
Conclusions: Hypertrophic chondrocytes may be restricted to
the articular cartilage in patients suffering from OA, and markers
of hypertrophic chondrocytes may as such be sensitive and
specific markers for early OA. The articular cartilage explants
model can be used as a new system of early OA, that allow
isolated investigations of potential novel treatments, which at
best would reverse this pathological phenotype.
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REGULATION OF PROSTAGLANDIN E-2 PRODUCTION IN
INTERLEUKIN ONE BETA ACTIVATED CHONDROCYTES
PROPAGATED ON MICROCARRIER SPINNER CULTURE
C.G. Frondoza1, J.L. Demko2, P.V. Phan1, E.A. Kramer3,
R. McLaughlin2
1Nutramax Laboratories, Inc., Edgewood, MD, 2Mississippi State
University, Mississippi State, MS, 3Johns Hopkins University,
Baltimore, MD
Purpose: The present study was designed to evaluate whether
chondrocytes propagated in microcarrier spinner culture can be
activated by IL-1β to produce PGE-2; and whether this activa-
tion can be blocked by natural products known to have anti-
inflammatory activity: Avocado Soybean Unsaponifiables (ASU),
glucosamine (Glu), and chondroitin sulfate (CS).
Methods: Canine chondrocytes (4x103/cm2) seeded in colla-
gen microcarrier beads were propagated in spinner culture for
14 days. They were next incubated with: media alone or the
combination of ASU (NMX-1000TM, 25μg/mL), CS (TRH122®,
20μg/mL) and Glu (FCHG49®, 10μg/mL). for 24 hrs. The com-
bination of ASU, Glu, and CS was supplied by Nutramax Labo-
ratories, Inc. Cultures were then incubated with media alone or
activated with IL-1β (10 ng/mL) at 37°C, 5% CO2 for 24 hrs. The
supernatant was assayed for PGE-2 content. Chondrocytes were
analyzed by microscopy and immunofluorescence for type II col-
lagen. Data was analyzed by ANOVA with the Tukey post-hoc
test. Values of p<0.05 were considered statistically significant.
Results: Chondrocytes attached, multiplied on microcarriers,
and produced extracellular matrix material. The cultures formed
aggregates and immunostained for type II collagen, indicating
continued production of the protein. Activation of chondrocyte-
seeded microcarriers at passage 3 and 4 showed similar re-
sponsiveness to the cytokine with IL-1β, PGE-2 levels of 179%
and 165% of non-activated controls, respectively. Pretreatment of
chondrocyte-seeded microcarriers with the combination of ASU,
Glu, and CS significantly reduced PGE-2 levels to about 60%
below non-activated controls (p<0.05).
Conclusions: The present study demonstrates that the micro-
carrier spinner culture system can be used to evaluate chon-
drocyte responses to pro-inflammatory stimuli and to identify
agents that can modify these responses. The dynamic condition
in the microcarrier spinner bioreactor appears to recapitulate the
biomechanical environment that chondrocytes encounter in the
joint. Therefore, the microcarrier spinner culture system may rep-
resent a useful tool to evaluate the potential anti-inflammatory
properties of natural products. Using this culture system, we
observed that the combination of ASU, Glu, and CS effectively
blocks activation of the inflammatory pathway.
P195
INHIBITION OF MITOGEN KINASE PHOSPHATASE 1
(MKP-1) POTENCIATES CELL DEATH INDUCED BY
TUMOR NECROSIS FACTOR α (TNFα) BUT NOT BY
INTERLEUKIN 1 β (IL-1β) IN NORMAL HUMAN
ARTICULAR CHONDROCYTES
B. Caramés, M.J. López-Armada, M. Lires-Deán,
B. Cillero-Pastor, B. Lema, F.J. Blanco
Osteoarticular and Aging Research Laboratory. Biomedical
Research Center, CHU "Juan Canalejo", Coruña, Spain
Purpose: Death of chondrocyte cells by apoptosis is a hallmark
of degenerative joint diseases such as osteoarthritis (OA). Tu-
mor necrosis factor α (TNF-α) and interleukin-1β (IL-1β) have
been demonstrated to play a pivotal role in the development of
OA disease. Previously we demonstrated that TNFα and IL-1β
differently regulate Actinomicyn D (Act D)-mediated apoptosis of
human chondrocytes.
Objective: This study addresses whether TNF-α and IL-1β differ-
ently modulate the cell death induced by Mitogen Kinase Phos-
phatase 1 inhibitor (Ro 31-8220) in normal human chondrocytes.
Methods: Normal human chondrocytes were isolated from knee
cartilage obtained from necropsy from 16 adult cadavers (mean
age 37 years). Ro (10 μg/ml) were used to induce apoptosis in
chondrocytes. Apoptosis were evaluated by using flow cytometry
(propidium iodide) and nuclear morphology was evaluated with
4’,6’-Dianidino-2-phenylindole dihidrochloride (DAPI) by fluores-
cence microscopy. As a control, cell death was induced in Jurkat
cells with staurosporine (1μM). Caspase-7, -3, bcl-2, mcl-1 and
FLICE-inhibitory protein (FLIP) were analyzed by Western-blot.
Results: We demonstrated that the level of hypodiploid peak
induced by TNF-α (10 ng/ml) + Ro increased significantly cell
death induced by Ro (Ro: 7.99±5.3%; TNF-α+Ro: 23.05±7.3%,
n=3, p<0,0001) at 24 hours. Notably, IL-1β (5 ng/ml) unlike
TNF-α, not showed this synergistic effect with Ro (IL-1β+Ro:
5.93±3.93%). These results are in agree with nuclear morpho-
logical analysis, which demonstrated that the treatment with
TNF-α+Ro resulted in a high number of cells condensed nuclei,
not observed with IL-1β+Ro treatment. Furthermore, western blot
studies indicated that IL-1β+Ro did not induce the activation of
caspase-7 and -3 observed in a time dependent manner with
TNF-α+Ro. On the other hand, this different effects were not due
to the antiapoptotic proteins bcl-2, mcl-1 or FLIP apoptosis in-
hibitor protein that decrease in the same level in both conditions.
To elucidate the role of the caspases on the effect of TNF-α
on chondrocyte cell death induced by Ro, caspase inhibitors
were employed (-3, -3/7, -8 and general) and hypodiploid DNA
